Healthcare

Friday's trading session revealed cracks in the artificial intelligence rally that has propelled technology stocks to dizzying heights for months....

enVVeno Medical's stock continued its dramatic descent on Friday, registering an additional 8.14% decline. This sustained sell-off was triggered by...

Australian biotechnology firm Immuron has initiated an unusually proactive communication strategy as it approaches two critical clinical milestones. The developer...

Renalytix AI shares are facing significant turbulence as UBS Group AG has completely divested its substantial stake in the artificial...

Industrial technology firm Idex finds itself navigating turbulent waters as divergent forces shape its trajectory. While a strategic acquisition in...

Pulmatrix Inc. is executing a profound strategic transformation, marked by its pending merger with Cullgen and the complete divestiture of...

The financial services giant Charles Schwab finds itself at a curious crossroads. On one hand, the firm is delivering an...

Krystal Biotech is implementing a significant strategic pivot in response to recent regulatory developments at the U.S. Food and Drug...

Despite a modest pullback to close the week, market experts remain overwhelmingly optimistic about Nkarta Inc. The biotech firm’s shares...

Independent oil and gas producer PrimeEnergy has reported a substantial contraction in its second-quarter financial performance, with both revenue and...